[Fullerenes in the treatment of respiratory disorders].
Diseases of respiratory organs constitute a serious socio-medical problem in this country due to high morbidity, mortality, and disability rates. The development of medical nanotechnlogies opens up new prospects for the improvement of treatment and prevention of these pathologies. Of special interest is application of C60fullerenes with a broad spectrum of therapeutic activities and synthesis of their hydrated forms for enteral and parenteral administration producing no acute or chronic toxic effects.
Shirinkin
S V
SV
Churnosov
M I
MI
Karapetian
T A
TA
D005609:Free Radicals / Q000037:antagonists & inhibitors; D037741:Fullerenes / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000517:prevention & control; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy; D012120:Respiration Disorders / Q000188:drug therapy*
D005609:Free Radicals; D037741:Fullerenes